Cracking the Code:
Genomic Testing to Advance Cancer Care in the GCC
Saturday, April 12 | 12:00 a.m.–12:30 p.m.
Hosted by: OncoHelix Inc.
Faisal M. Khan, Ph.D., D(ABHI), CEO & Director, OncoHelix Inc.
In this presentation, we will discuss the role of cancer genomic testing in transforming cancer care through better cancer diagnosis, improved risk stratification, personalized treatment plans, and improved patient outcomes.
Key Insight:
- Different roles of single gene assessment, multi-gene hot spot NGS profiling, and comprehensive genomic profiling on precision oncology
- Highlighting initiatives, discoveries, challenges, and future prospects
Objectives:
- Role of cancer genomic testing in improving cancer diagnosis, risk stratification, and choices of targeted therapy
- Different roles of single gene assessment, multi-gene hot spot NGS profiling, and comprehensive genomic profiling in precision oncology
- Value for Clinical Labs, Translational research, Health care providers and their patients.
